IntegenX Launches Next-Generation Rapid Forensic DNA Platform | GenomeWeb

NEW YORK (GenomeWeb) — IntegenX, a manufacturer of short tandem repeat PCR-based rapid DNA profiling platforms, has launched a next-generation instrument.

Called RapidHit ID, the platform processes a single buccal swab in about 70 minutes with little hands on time and no laboratory expertise required.

The new instrument is ultimately designed to enable decentralized DNA testing of suspects in places like booking stations and police precincts, and the cost of running samples on it will be about one quarter that of the firm's first-generation platform, the RapidHit System.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.